Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index; 57 of the 178 sources its claims cite were checked for support.

Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review

Open access
Anderson, William J., da Cruz, Natasha Ferreira Santos, Lima, Luiz Henrique, Emerson, Geoffrey G., Rodrigues, Eduardo Büchele, Melo, Gustavo Barreto · 2021 · International Journal of Retina and Vitreous

Abstract

Background: Intraocular inflammation is an uncommon but potentially vision-threatening adverse event related to anti-VEGF therapy. This is of increasing importance given both the volume of injections performed, as well as the increased prevalence of inflammation seen with newer anti-VEGF agents. Brolucizumab, the newest anti-VEGF agent, has been associated with an inflammatory retinal vasculitis and the underlying mechanism is unclear. Reviewing potential mechanisms and clinical differences of intraocular inflammation may assist clinicians and scientists in reducing the risk of these events in the future. Observations: Two types of inflammation are seen with intravitreal injections, acute onset sterile inflammation and delayed onset inflammatory vasculitis. Acute onset inflammation can be subcategorized into subclinical anterior chamber inflammation and sterile uveitis/endophthalmitis. Subclinical anterior chamber inflammation can occur at rates as high as 19% after intravitreal anti-VEGF injection. Rates of sterile uveitis/endophthalmitis range from 0.05% to 4.4% depending on the anti-VEGF agent. Inflammatory vasculitis is only associated with brolucizumab and occurred in 3.3% of injections according to the post hoc review of the HAWK/HARRIER data. In addition, silicone oil from syringes can induce immunogenic protein aggregates. Agitation of the syringe, freeze thawing, shipping and improper storage prior to injection may increase the amount of silicone oil released from the syringe. Conclusion: The main factors which play a role in intraocular inflammation after anti-VEGF injection can be divided into three causes: patient-specific, medication-specific and delivery-specific. The majority of clinically significant inflammation seen after intravitreal injection is an acute onset inflammatory response with most patients recovering baseline VA in 3–5 weeks. The presence of pain, hypopyon, severe anterior chamber reaction, hyperemia and significant vision loss may help distinguish infectious from non-infectious etiologies of post injection inflammation. Avoiding temperature fluctuation, mechanical shock, agitation during transport and handling of syringes/drugs, and the use of SO-free syringes may help minimize intraocular inflammation. While a definitive mechanism has not yet been established, current knowledge of the clinical presentation and vitreous histopathology of brolucizumab-retinal vasculitis favors an auto-immune type IV hypersensitivity reaction.

Overview

CoChat Summary

TL;DR

This narrative review summarizes sterile intraocular inflammation after intravitreal anti-VEGF injection, dividing it into acute onset sterile inflammation and delayed onset inflammatory vasculitis. It highlights patient-, medication-, and delivery-specific factors, especially silicone oil/protein aggregation and brolucizumab-associated type IV hypersensitivity.

Key findings

  • Acute onset sterile inflammation ranges from subclinical anterior chamber inflammation, reported as high as 19% after anti-VEGF injection, to sterile uveitis/endophthalmitis, with rates from 0.05% to 4.4% depending on the agent.
  • Inflammatory vasculitis is associated only with brolucizumab in this review; post hoc HAWK/HARRIER review reported inflammation and concomitant retinal vasculitis in 3.3% and vascular occlusion in 2.1%, with about 22% of vasculitis patients losing >15 ETDRS letters.
  • An ASRS retrospective series of 26 eyes found BCVA worsened from 20/52 at baseline to 20/151 at presentation, mean final BCVA 20/243, 46% with >3-line visual acuity decrease, and occlusive vasculitis in 85%.
  • Silicone oil from syringes can induce immunogenic protein aggregates; agitation, freeze-thawing, shipping, and improper storage may increase silicone oil release, and avoiding syringe flicking and using SO-free syringes may reduce inflammation.

Methods

  • Narrative review using PubMed to identify English-language articles published through March 25, 2021, with search terms including anti-VEGF, inflammation, sterile endophthalmitis, uveitis, intravitreal injections, and sterile inflammation.
  • The final literature set comprised 84 articles; because of a lack of randomized clinical trials, the authors also included case reports, case series, and review articles.
  • Titles and abstracts were reviewed for inclusion, and additional articles were identified from citations and similar PubMed papers; findings were synthesized narratively.

Limitations

  • The paper states that randomized clinical trials were lacking, so case reports, case series, and review articles were included.
  • The paper states that the small number and heterogeneity of brolucizumab-associated vasculitis cases made clarifying a causative factor difficult, and a definitive mechanism has not been established.
  • Evident from the text: as a narrative review, it does not report a systematic quality appraisal or meta-analytic synthesis of the included evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40942-021-00307-7

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Schematic drawing illustrating possible interactions between silicone oil (SO) and proteins in solution. Proteins may undergo conformational change and film formation after interaction with the silicone oil surface. Fragmentation of SO-protein complexes results in smaller aggregates and agglomerates
Fig. 1 Schematic drawing illustrating possible interactions between silicone oil (SO) and proteins in solution. Proteins may undergo conformational change and film formation after interaction with the silicone oil surface. Fragmentation of SO-protein complexes results in smaller aggregates and agglomeratesCC BY · PubMed Central
Fig. 2 Contributing factors of inflammation
Fig. 2 Contributing factors of inflammationCC BY · PubMed Central

Verification

Claims the paper makes

45 Valid · 11 Not valid · 63 Not checked · 51 Own results and interpretations

99 more claims · 30 with their cited sources checked

Create a free account to see all 170 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 49

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 82 references

Cited by

See all 155

Metadata

Authors
Anderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B.
Affiliations
  • Saint Louis University (US)
  • Universidade Federal de São Paulo (BR)
  • The Retina Center (US)
Corresponding author
Melo, Gustavo Barreto
Venue
International Journal of Retina and Vitreous
Published
2021-05-07
Volume
7
Issue
1
Pages
37-37
ISSN
2056-9920 (ISSN-L)
OpenAlex
W3157686683
Cited by
155
References
82
Citations by year
2026: 36 · 2025: 38 · 2024: 32 · 2023: 25 · 2022: 19 · 2021: 5
FWCI
3.48
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Retina and Vitreous (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
sterile inflammation, intraocular inflammation, anti-VEGF therapy, intravitreal injection, brolucizumab, retinal vasculitis, endophthalmitis, silicone oil, delayed-type hypersensitivity, adverse events

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review. https://app.cochat.ai/papers/10.1186/s40942-021-00307-7
The paper
Anderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B. (2021). Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review. International Journal of Retina and Vitreous. https://doi.org/10.1186/s40942-021-00307-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.